FindTrial
Sign In

Loss of Muscle Mass and Strength in Women with Breast Cancer Recieving Chemoradiation Therapy

Sarcopenia in Female Patients with Breast Cancer receiving Chemoradiation Therapy: A Longitudinal Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/090167
Enrollment
80
Registered
2025-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: M625- Muscle wasting and atrophy, not elsewhere classified

Interventions

Intervention1: Nil: Nil

Sponsors

Sampras Dsouza
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with carcinoma of breast Gender: Females English speaking patients Patients admitted at FMMC Patients above 18 years of age Patients yet to begin Chemoradiation therapy.

Exclusion criteria

Exclusion criteria: Cognitive impairment with inability to understand commands Patients with recent fracture of upper or lower limbs Hemodynamically unstable patients Patients with hemoglobin less than 8 mg/dl

Design outcomes

Primary

MeasureTime frame
Estimate the changes in muscle mass, muscle strength and physical functionTimepoint: 1st week(before the commencement of chemoradiation therapy) 3rd week 7th week—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactSampras Dsouza

Father Muller College of Physiotherapy

samprasdsouza3000@gmail.com9535486134

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026